Injection to reduce fat in half a year Anti-Obesity drugs

Injection-reduce-fatA medicine has been recently developed for obese people which aids in cutting down the weight by twice the size.

The drug will be available in three years, its Danish maker has said.

Novo Nordisk, the Danish pharmaceutical producer, stated that liraglutide could also help reduce blood pressure levels, at the same time increase “good” cholesterol and aid in regulation of diabetes, the Daily Mail reported today.

The medicine can be injected by the aid of pen-like-device which is based on incretin, a gut hormone that helps signal the brain when it is time to put a halt on eating at the same time breaks down within minutes of being generated. In contrast, the drug persists in the blood for hours.

The firm is presently carrying out large-scale, carrying trials on 5,000 obese men and women. It will soon be ending in 2013.

In the first phase of the trials, close to 550 male and female volunteers, who’ve fought for their brand name for continuous years, losing standard of more than six months, according to the findings.

Viggo Birch, managing director of Novo Nordisk, said: “We have had phenomenal results from the first clinical trials in obesity. The effects on confidence and health were life-changing.